Management of cancer of the base of tongue

被引：7

作者：

Han, P

Hu, K

Frank, DK

Sessions, RB

Harrison, LB

机构：

[1] St Lukes Roosevelt Hosp, New York Eye & Ear Infirm, Beth Israel Med Ctr, Continuum Canc Ctr New York, New York, NY 10025 USA

[2] Albert Einstein Coll Med, New York, NY USA

来源：

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2005年 / 38卷 / 01期

关键词：

D O I：

10.1016/j.otc.2004.10.016

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

The management of base of tongue cancer has evolved steadily over time. Organ preservation with primary radiation therapy has produced excellent oncologic and functional outcomes. Concomitant chemotherapy has become important in patients with locoregionally advanced disease. Planned neck dissection after organ preservation therapy continues to be an integral step for regional control. This article reports the results of a literature review of base of tongue cancer emphasizing a multidisciplinary approach to obtain optimal results in terms of cure and quality of life.

引用

页码：75 / +

页数：12

共 37 条

[1] Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [J].

Adelstein, DJ ;

Li, Y ;

Adams, GL ;

Wagner, H ;

Kish, JA ;

Ensley, JF ;

Schuller, DE ;

Forastiere, AA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :92-98

[2] Organ preservation with interstitial radiation for base of tongue cancer [J].

Barrett, WL ;

Gleich, L ;

Wilson, K ;

Gluckman, J .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05) :485-488

[3]

Bourhis J, 1996, ANTICANCER RES, V16, P2397

[4] Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer [J].

Brizel, DM ;

Prosnitz, RG ;

Hunter, S ;

Fisher, SR ;

Clough, RL ;

Downey, MA ;

Scher, RL .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05) :1418-1423

[5] Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer [J].

Brizel, DM ;

Albers, ME ;

Fisher, SR ;

Scher, RL ;

Richtsmeier, WJ ;

Hars, V ;

George, SL ;

Huang, AT ;

Prosnitz, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1798-1804

[6]

Brunin F, 1999, HEAD NECK-J SCI SPEC, V21, P751, DOI 10.1002/(SICI)1097-0347(199912)21:8<751::AID-HED11>3.3.CO

[7]

2-W

[8] Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma [J].

Denis, F ;

Garaud, P ;

Bardet, E ;

Alfonsi, M ;

Sire, C ;

Germain, T ;

Bergerot, P ;

Rhein, B ;

Tortochaux, J ;

Calais, G .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :69-76

[9] Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience [J].

Fein, DA ;

Lee, WR ;

Amos, WR ;

Hinerman, RW ;

Parsons, JT ;

Mendenhall, WM ;

Stringer, SP ;

Cassisi, NJ ;

Million, RR .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02) :289-296

[10] Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer [J].

Forastiere, AA ;

Goepfert, H ;

Maor, M ;

Pajak, TF ;

Weber, R ;

Morrison, W ;

Glisson, B ;

Trotti, A ;

Ridge, JA ;

Chao, C ;

Peters, G ;

Lee, DJ ;

Leaf, A ;

Ensley, J ;

Cooper, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2091-2098

← 1 2 3 4 →